rheumatology
Osteoporosis

Task Force comes out against vertebroplasty


Percutaneous vertebroplasty provides no demonstrable clinical benefit over placebo or sham procedures in patients with vertebral fractures, according to an international Task Force auspiced by the American Society for Bone and Mineral Research (ASBMR). The findings are of particular interest in Australia given that the Medical Services Advisory Committee (MSAC) have been reconsidering re-listing the ...

Already a member?

Enter your email to keep reading.


OR